Professional Documents
Culture Documents
Managers of The Year Rev 1
Managers of The Year Rev 1
Recently named Time Magazine’s Person of the Year (the first woman to get the designation
in 29 years), Merkel has also been called the most powerful woman in the world in her 10 -
Merkel earned the latter role by helping to keep the crisis of the euro–a currency shared by 19
But another, more startling move on Merkel’s part in 2015 was to allow refugees and migrants
to seek asylum in Germany, when many other countries were closing their borders. Estimates
put the number of people entering the country at 1 million by the end of this year. It was a
natural decision for Merkel, who grew up in East Germany when the country was sharply
divided and citizens were not allowed to travel to the West until they reached age 60. At a
security conference in Munich this year, she reiterated her stance on patience and principles.
passive equality policy, Result : Women’s employment rate become higher, Her
1
government promises to improve child care system and parental leave, ensure equality
Merkel's successful career can only be understood by studying the internal party
dynamics leadership approach. Merkel owes her initial rise to prominence within the her
ability to help the party satisfy a variety of informal internal party quotas. She primarily
followed the party manager approach to leadership, balancing tensions among various
internal party groups while avoiding affiliating herself with any group in particular.
Pharmaceuticals
In one night, the cost of a drug that had been on the market for 62 years shot up from $13.50
per tablet to $750 per tablet. Daraprim is used to treat the life-threatening parasitic infection
toxoplasmosis in pregnant women and their unborn babies, and people with compromised
immune systems as a result of illnesses like cancer and AIDS. It’s also used to treat malaria.
Shkreli, the 32-year-old founder of startup Turing Pharmaceuticals, had just acquired the drug
and immediately hiked the price, making the cost to patients exceed hundreds of thousands of
dollars. Arguing that it wasn’t a greedy move because most patients would use the medicine
for less than a year, Shkreli argued that this would make way for better drugs with fewer side
effects.
2
And if that sounds pretty bad, there are elements that make it worse. A New York Times report
found that doctors weren’t convinced a new drug needed to be developed. Shkreli has been
He started MSMB Capital, a hedge fund company, in his 20s and drew attention for urging the
Food and Drug Administration not to approve certain drugs made by companies whose stock he
was shorting.
In 2011, Mr. Shkreli started Retrophin, which also acquired old neglected drugs and sharply
raised their prices. Retrophin’s board fired Mr. Shkreli a year ago. Last month, it filed a
complaint in Federal District Court in Manhattan, accusing him of using Retrophin as a personal
emotions work for you, rather than against you, There's no denying Martin Shkreli's
investments, before his foray into the pharmaceutical industry. Associates have
3
c) Cite an example of management function where they perform poorly.
Received widespread criticism when Turing obtained the manufacturing license for
the antiparasitic drug Daraprim and raised its price leading him to be referred to by the
media as "the most hated man in America" and "'Pharma Bro”. Shkreli was charged in
federal court, then convicted on two counts of securities fraud and one count of
References:
https://www.fastcompany.com/3054777/the-10-best-and-worst-leaders
https://www.slideshare.net/AidaPourshirazi/angela-merkel-leadership-traits
https://www.google.com/search?q=Martin+Shkreli+traits